hypertriglyceridemia

Arrowhead Pharmaceuticals’ New Drug Plozasiran Shows Promise in Treating Rare Genetic Disease

Arrowhead Pharmaceuticals announced positive results from its Phase 3 PALISADE study on plozasiran, a new drug for treating familial chylomicronemia syndrome (FCS). FCS is a rare genetic condition that causes extremely high triglyceride levels, leading to serious health issues like acute pancreatitis. Currently, there are no approved treatments for FCS in the United States or

vaccine

US Food and Drug Administration Approves New Pneumococcal Vaccine

Merck & Co.’s new vaccine, CAPVAXIVE (V116), has been approved by the FDA for preventing invasive diseases and pneumonia in adults 18 and older caused by specific strains of the bacteria Streptococcus pneumoniae. This vaccine is particularly aimed at protecting adults over 50 from around 84% of invasive pneumococcal diseases. In several studies, CAPVAXIVE showed

health care

The Impact of Healthcare Privatization on Quality of Care: Insights from 13 Studies

In a comprehensive meta-analysis spanning 13 longitudinal studies across high-income countries, researchers scrutinized the effects of healthcare privatization on patient care quality. Covering nations including Canada, Croatia, USA, and others, the analysis assessed changes before and after privatization, focusing on indicators like staffing, patient mix, and health outcomes.  The meta-analysis revealed a concerning trend: privatization

Psoriatic Arthritis Symptoms Causes + Self-Management, psoriasis

Study Results – Amgen Posts Promising Results for Psoriatic Arthritis

Today the Team at JoinAStudy.ca would like to acknowledge the dedicated work of one of our Investigators, Dr. Sabeen Anwar. Dr. Anwar and her team have played a key part in gathering new data to advance the knowledge of patient care for the condition of Psoriatic Arthritis.  The APPRAISE study, a prospective observational investigation conducted

cinnamon

Prediabetics May Benefit from Taking Cinnamon Supplements

In a recent randomized, controlled, double-blind trial, researchers in the United States investigated the impact of a modest daily intake of 4g of cinnamon supplements over four weeks on blood glucose levels. The study, extended with continuous glucose monitoring (CGM) and oral glucose tolerance test (OGTT) data, focused on participants with obesity and prediabetes. Contradictory